There has been previous discussion on this forum about the need for vaccination after having a prior COVID infection.
New data released yesterday from a study in Nature suggests that prior infection with COVID provides significantly reduced neutralizing antibodies to the delta variant, opening the potential for re-infection with COVID and development of severe disease even with prior COVID exposure. Antibodies also decrease with time after exposure (those who had COVID a year+ ago will have worse protective antibody titers)
Additionally, having only one dose of either mRNA vaccines -- Pfizer or Moderna -- also shows significantly reduced neutralizing antibodies compared to two doses.
Please get vaccinated today even if you have had COVID previously to protect yourself and your loved ones. Also, make sure to get both doses as the data clearly shows protection and value of obtaining both doses.
Quotes from the research study and links:
Summary -- unvaccinated individuals with prior COVID infection show reduced antibody titers to the Delta variant compared to other variants.
Summary: Antibody titers were high and provided protection in individuals who had prior COVID infections and were then vaccinated compared to those who had COVID infections and were unvaccinated. Vaccination provides neutralizing antibodies against all variants tested, while unvaccinated even with prior COVID exposure provides reduced protection that decreases over time (1 year +). The data also shows that a single vaccine dose is protective for those individuals that had a COVID infection.
Summary: In people that had no prior COVID infection, both vaccine doses are needed to provide high amounts of neutralizing antibodies. A single dose is not enough.
Link to the paper:
https://www.nature.com/articles/s41586-021-03777-9_reference.pdf
New data released yesterday from a study in Nature suggests that prior infection with COVID provides significantly reduced neutralizing antibodies to the delta variant, opening the potential for re-infection with COVID and development of severe disease even with prior COVID exposure. Antibodies also decrease with time after exposure (those who had COVID a year+ ago will have worse protective antibody titers)
Additionally, having only one dose of either mRNA vaccines -- Pfizer or Moderna -- also shows significantly reduced neutralizing antibodies compared to two doses.
Please get vaccinated today even if you have had COVID previously to protect yourself and your loved ones. Also, make sure to get both doses as the data clearly shows protection and value of obtaining both doses.
Quotes from the research study and links:
Quote:
We examined the neutralization ability of sera from convalescent subjects. We first selected samples from 56 donors in a cohort of infected individuals from the French city of Orlans. All individuals were diagnosed with SARS-CoV-2 infection by RT-qPCR or serology and included critical, severe, mild-to-moderate and asymptomatic cases (Extended Data Table 1). They were not vaccinated at the sampling time. We recently characterized the potency of these sera against D614G, Alpha and Beta isolates11. We analyzed individuals sampled at a median of 188 days post onset of symptoms (POS), referred to as Month 6 (M6) samples. We calculated ED50 (Effective Dose 50%) for each combination of serum and virus (Extended Data Fig. 7a). With the Alpha variant, we obtained similar ED50 values in this series of experiments than in our previous analysis11 (Extended Data Fig. 7b). We thus included our published data for D614G and Beta in the comparison. With Delta, neutralization titers were significantly decreased by 4 to 6-fold when compared to Alpha and D614G strains, respectively (Extended Data Fig. 7a). This reduction in neutralizing titers was similar against Delta and Beta (Extended Data Fig. 7a).
Summary -- unvaccinated individuals with prior COVID infection show reduced antibody titers to the Delta variant compared to other variants.
Quote:
We asked whether this neutralization profile was maintained for longer periods of time. We analyzed sera from 47 individuals from another cohort of RT-qPCR-confirmed health care workers from Strasbourg University Hospitals who experienced mild disease. Twenty six individuals were unvaccinated, whereas 21 received a single dose of vaccine 7-81 days before sampling. The samples were collected at a later time point (M12), with a median of 330 and 359 days for unvaccinated and vaccinated individuals, respectively (Extended Data Table 1)23. As observed, the neutralization activity was globally low at M12 in unvaccinated individuals (Fig. 2a). There was a 4 fold decrease of ED50 against Beta and Delta, relative to Alpha (Fig. 2a). The 21 single-dose vaccine recipients of the M12 cohort included 9 vaccinated with AstraZeneca, 9 with Pfizer and 3 with Moderna vaccines. Sera from these vaccinated participants showed a dramatic increase in neutralizing antibody titers against Alpha, Beta and Delta variants, as compared to unvaccinated convalescents (Fig. 2a). Therefore, as shown with other variants a single dose of vaccine boosts cross-neutralizing antibody responses to Delta. We then classified the cases as neutralizers (defined as harboring neutralizing antibodies detectable at the first serum dilution of 1/30) and non-neutralizers, for the viral variants and the two cohorts (Extended Data Fig. 7c). Between 76% and 92% of the individuals neutralized the four strains at M6. The fraction of neutralizers was lower in the second cohort at M12, a phenomenon which was particularly marked for Beta and Delta. 88% of individuals neutralized Alpha and only 47% neutralized Delta. After vaccination, 100% of convalescent individuals neutralized the four strains (Extended Data Fig. 7c). Thus, variant Delta displays enhanced resistance to neutralization by sera from unvaccinated convalescent individuals, particularly one year after infection.
Summary: Antibody titers were high and provided protection in individuals who had prior COVID infections and were then vaccinated compared to those who had COVID infections and were unvaccinated. Vaccination provides neutralizing antibodies against all variants tested, while unvaccinated even with prior COVID exposure provides reduced protection that decreases over time (1 year +). The data also shows that a single vaccine dose is protective for those individuals that had a COVID infection.
Quote:
In individuals that were not previously infected with SARS-CoV-2, a single dose of either Pfizer or AstraZeneca vaccines barely induced neutralizing antibodies against variant Delta. About 10% of the sera neutralized this variant. However, a two-dose regimen generated high sero-neutralization levels against variants Alpha, Beta and Delta, in subjects sampled at W8 to W16 post vaccination.
Summary: In people that had no prior COVID infection, both vaccine doses are needed to provide high amounts of neutralizing antibodies. A single dose is not enough.
Link to the paper:
https://www.nature.com/articles/s41586-021-03777-9_reference.pdf